Please assess the completion status of the following clinical trial:

Trial Title: Creon in HIV Patients With Steatorrhea

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria HIV positive patients with clinically stable disease (Karnofsky Performance Status \> 40);~* Steatocrit \> 2 %;~* Females of child-bearing potential must have a negative pregnancy test during prestudy or the subject must be surgically sterile or be at least 1 year postmenopausal as judged by the investigator;~* Women of child-bearing potential must be using a medically acceptable method of birth control throughout the study~Exclusion Criteria~* Known allergy to pancreatin or any history of abnormal drug reaction;~* Known diagnosis of pancreatic exocrine insufficiency due to e.g. chronic pancreatitis or cystic fibrosis or pancreatectomy;~* Intake of an experimental drug within four weeks prior to entry into the study;~* Alcohol abuse within the last six months;~* Suspected non-compliance or non-cooperation;~* Any other lack of fitness, in the investigator's opinion, to participate in or to complete the study;~* Patients with a stool fat excretion \<= 7 g/day according to van de Kamer during the run-in period

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).